Diltiazem tablets/capsules bulk supplier for pharma manufacturers

Diltiazem Tablets/Capsules Suppliers & Bulk Manufacturers

Available Forms: Tablet/Capsules

Available Strengths: IR: 0 mg, 60 mg, 90 mg, 120 mg; SR: Up to 540 mg

Reference Brands: Cardizem(US); Dilzem(EU)

Diltiazem is a calcium channel blocker that relaxes blood vessels and reduces heart rate by inhibiting calcium entry into cardiac and vascular smooth muscle cells. It effectively treats hypertension, angina, and arrhythmias, providing benefits like lowered blood pressure, decreased chest pain, rhythm stabilization, and improved overall cardiovascular health.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Diltiazem Tablets/Capsules? List it or send an offer →

Product Description:

Diltiazem tablets and capsules, marketed as Cardizem and Dilzem, are approved in the US by the FDA and in the EU via EMA for hypertension, angina, and arrhythmias. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, FDA reviews clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing standards. Proper regional compliance supports timely approval, safe use, and global availability, enabling effective cardiovascular management worldwide.

Diltiazem Tablets/Capsules — third party manufacturing & bulk supply

Diltiazem Tablets/Capsules is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Diltiazem Tablets/Capsules is supplied as Tablet/Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Diltiazem Tablets/Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Diltiazem Tablets/Capsules →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Diltiazem tablets/capsules is listed as Tablet/Capsules in IR: 0 mg, 60 mg, 90 mg, 120 mg; SR: Up to 540 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Diltiazem tablets/capsules is referenced against Cardizem(US); Dilzem(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.